Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

5.63
+0.05000.90%
Post-market: 5.630.00000.00%16:05 EDT
Volume:110.34K
Turnover:621.79K
Market Cap:120.10M
PE:-1.14
High:5.80
Open:5.56
Low:5.56
Close:5.58
Loading ...
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Mar 05, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Major Issues Report

8-K - Current report
Feb 05, 2021

Major Issues Report

8-K - Current report
Jan 28, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 04, 2020

Major Issues Report

8-K - Current report
Nov 25, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 23, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2020

Major Issues Report

8-K - Current report
Jun 30, 2020

Major Issues Report

8-K - Current report